392 results on '"Nalbantgil S"'
Search Results
2. EE280 Economic Burden of Hyperkalemia in Turkey
3. INDIRECT COSTS IN HEART FAILURE IN TURKEY: A DELPHI PANEL BASED ANALYSIS IN RELATION TO NYHA CLASSES
4. COST-OF-DISEASE IN HEART FAILURE IN TURKEY: A DELPHI PANEL BASED ANALYSIS OF DIRECT COSTS
5. POSC164 Cost-of-Disease in Heart Failure in Turkey: A Delphi Panel Based Analysis of Direct Costs
6. POSB164 Indirect Costs in Heart Failure in Turkey: A Delphi Panel Based Analysis in Relation to Nyha Classes
7. Transthoracic echocardiographic and cardiopulmonary exercise testing parameters in Eisenmenger’s syndrome: Association with six-minute walk test distance
8. Risk assessment tool implementation in congenital heart disease associated pulmonary arterial hypertension
9. Outcomes in LVAD Implantation via Lateral Thoracotomy with Outflow Cannula Anastomosis to the Descending Aorta
10. A Sparse Approximation Based Algorithm to Detect Aortic Valve Opening from HVAD Waveforms Acquired via Monitor Snapshot
11. The experience of Ege University heart failure group with continous-flow pump: P257
12. Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy
13. Outcomes in LVAD Implantation via Lateral Thoracotomy with Outflow Cannula Anastomosis to the Descending Aorta
14. A Sparse Approximation Based Algorithm to Detect Aortic Valve Opening from HVAD Waveforms Acquired via Monitor Snapshot
15. Evaluation of the REVEAL 2.0 simplified three-category model in a pulmonary arterial hypertension cohort enriched with congenital heart disease
16. Device thrombosis in the Heartware LVAD treatment decision and role of log files
17. Turkish Cardiology Association Consensus report: COVID-19 pandemic and cardiovascular diseases (May 13, 2020)
18. Pulmonary Complications in Heart Transplant Recipients
19. Evaluation of the REVEAL 2.0 simplified three-category model in a pulmonary arterial hypertension cohort enriched with congenital heart disease
20. Eye of Stranger: Evaluate of Chorioretinal Microvascular Networks on Ventricular Assist Device
21. The prevalence of silent myocardial ischaemia in patients with white-coat hypertension
22. Primary Cardiac Lymphoma in a Heart Transplant Recipient
23. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure
24. Burden and the clinical significance of the retained cardiac implantable electronic device components after heart transplantation
25. Noncompaction cardiomyopathy and cardiac MR imaging in Ege University
26. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension
27. Vaccination of adults with heart failure and chronic heart conditions: Expert opinion [Kalp yetersizliği ve kronik kalp hastalıklarında erişkin aşılama: Uzman görüşü]
28. P3140Burden and the clinical significance of the retained cardiac implantable electronic device components after heart transplantation
29. P462Noncompaction cardiomyopathy and cardiac MR imaging in Ege University
30. Frailty and Clinical Outcomes Following Left Ventricular Assist Device Implantation
31. Efficacy and Safety of Ferric Carboxymaltose Therapy in Continuous Flow LVAD Patients
32. Prospective Evaluation of LVAD Risk Scores’ Capacity to Predict Cardiopulmonary Exercise Parameters
33. Intracranial Hemorrage in Patients with Continous Flow LVAD
34. P5118Changes in plasma neprilysin levels after left ventricular assist device implantation and association with short-term outcomes
35. P3558Comparison of cardiac output measurement methods for mortality prediction in pulmonary hypertension
36. Pump Thrombosis in HeartWare HVAD Left Ventricular Assist Devices: Single Center Experience
37. Treatment of Pump Thrombosis With Low Dose Thrombolytic Therapy in Heartware HVAD Left Ventricular Assist Devices: Single Center Experience
38. Heartmate 3 versus Heartmate 2: Is New Always Better ?
39. P1122T peak to T end interval changes before and after left ventricular assist device implantation
40. Outcomes of Low Dose Strategy of Thrombolytic Therapy for Pump Thrombosis
41. Short-term Results of Heartmate 3 Ventricular Assist Device Implantation for End-Stage Heart Failure
42. Survival Benefit of Implantable Cardioverter Defibrillator Therapy on Patients with Left Ventricular Assist Device
43. Practical approach to acute heart failure with algorithms [Akut kalp yetersizli?ine algoritmalarla pratik yaklaşim]
44. The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey: An Expert Panel Approach for Estimation of Costs
45. The Direct Cost-Components in Pulmonary Arterial Hypertension: An Expert Panel Approach for Estimation of Costs
46. PS163 Tenascin-C Levels and Clinical Importance in Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
47. PM245 Correlation of Right Ventricle Free Wall Strain and Right Heart Catheterization in Pulmonary Arterial Hypertension
48. Diagnosis and Management of Pump Thrombosis in Patients with Continuous-Flow Ventricular Assist Devices
49. Risk Factors of Gastrointestinal Bleeding after Continuous Flow Left Ventricular Assist Device
50. The Effect of Cardiac Rehabilitation on Functional Capacity, Psychological Symptoms and Quality of Life in Patients with a Left Ventricular Assist Device
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.